Fragment-based strategy in drug design involves the initial discovery of low-molecular mass molecules. Owing to their small-size, fragments are molecular tools to probe specific sub-pockets within a protein active site. Once their interaction within the enzyme cavity is clearly understood and experimentally validated, they represent a unique opportunity to design potent and efficient larger compounds. Computer-aided methods can essentially support the identification of suitable fragments. In this review, available tools for computational drug design are discussed in the frame of fragmentbased approaches. We analyze and review (i) available commercial fragment libraries with respect to their properties and size, (ii) computational methods fo...
The development of JAFS, a new computational method to study the binding geometries of small fragmen...
We have designed four generations of a low molecular weight fragment library for use in NMR-based sc...
<div><p>Target-based drug discovery must assess many drug-like compounds for potential activity. Foc...
In this review, a general introduction to fragment-based drug design and the underlying concepts is ...
As fragment-based drug design has become established as a standard component of the drug discovery a...
Fragment-based drug design is an established strategy of finding new drugs. Instead of doing mass sc...
With the growth in fragment-based drug discovery, numerous strategies have been described for the de...
The use of fragments with low binding affinity for their targets as starting points has received muc...
Current fragment-based drug design relies on the efficient exploration of chemical space by using st...
Polypharmacology-based strategies are gaining increased attention as a novel approach to obtaining p...
This paper describes the use and validation of S4MPLE in Fragment-Based Drug Design (FBDD)a strateg...
Fragment-based drug discovery typically requires an interplay between screening methods, structural ...
Fragment-based drug discovery (FBDD) is well suited for discovering both drug leads and chemical pro...
Over the past decade, fragment-based drug discovery has developed significantly and has gained incre...
Fragment-based drug discovery (FBDD) is an important technology in drug discovery that seeks to iden...
The development of JAFS, a new computational method to study the binding geometries of small fragmen...
We have designed four generations of a low molecular weight fragment library for use in NMR-based sc...
<div><p>Target-based drug discovery must assess many drug-like compounds for potential activity. Foc...
In this review, a general introduction to fragment-based drug design and the underlying concepts is ...
As fragment-based drug design has become established as a standard component of the drug discovery a...
Fragment-based drug design is an established strategy of finding new drugs. Instead of doing mass sc...
With the growth in fragment-based drug discovery, numerous strategies have been described for the de...
The use of fragments with low binding affinity for their targets as starting points has received muc...
Current fragment-based drug design relies on the efficient exploration of chemical space by using st...
Polypharmacology-based strategies are gaining increased attention as a novel approach to obtaining p...
This paper describes the use and validation of S4MPLE in Fragment-Based Drug Design (FBDD)a strateg...
Fragment-based drug discovery typically requires an interplay between screening methods, structural ...
Fragment-based drug discovery (FBDD) is well suited for discovering both drug leads and chemical pro...
Over the past decade, fragment-based drug discovery has developed significantly and has gained incre...
Fragment-based drug discovery (FBDD) is an important technology in drug discovery that seeks to iden...
The development of JAFS, a new computational method to study the binding geometries of small fragmen...
We have designed four generations of a low molecular weight fragment library for use in NMR-based sc...
<div><p>Target-based drug discovery must assess many drug-like compounds for potential activity. Foc...